Aquestive Therapeutics In...

NASDAQ: AQST · Real-Time Price · USD
4.12
0.11 (2.74%)
At close: Aug 14, 2025, 3:59 PM
4.11
-0.12%
Pre-market: Aug 15, 2025, 08:59 AM EDT

Aquestive Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-44.14M -7.87M -54.41M -70.54M
Depreciation & Amortization
718K 1.34M 2.39M 2.96M
Stock-Based Compensation
7.1M 2.69M 4.38M 6.82M
Other Working Capital
-14.56M -259K 24.77M 414K
Other Non-Cash Items
10.52M 2.8M 5.85M 15.69M
Deferred Income Tax
n/a n/a n/a 13.82M
Change in Working Capital
-9.96M -5.34M 32.01M -1.73M
Operating Cash Flow
-35.76M -6.38M -9.79M -32.98M
Capital Expenditures
-159K -995K -2.52M -913K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-159K -995K -2.52M -913K
Debt Repayment
-23K -20.39M -2.02M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-142K 15.45M 1K 329K
Financial Cash Flow
83.59M 3.97M 11.56M 30.11M
Net Cash Flow
47.67M -3.4M -751K -3.78M
Free Cash Flow
-35.92M -7.38M -12.31M -33.89M